Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report

摘要

Pattern of change in ALT and bilirubin values from time of admission to discharge with timeline of immunosuppression, serial biopsies and readmission. Key: * timing of liver biopsies.